Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐<scp>BCMA CAR</scp> T‐cell‐based therapyYuekun Qi, Jiang Cao, Kunming Qi et al.|American Journal of Hematology|2024Cited by 21